Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen

Kyoko Nitta(Kanazawa Medical University), Daisuke Koya(Kanazawa Medical University)
BioMed Research International
January 1, 2016
Cited by 42


Related Papers